MCT Bioseparation Aps: Financial statements 2025
CVR: 41269774
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
MCT Bioseparation Aps (CVR 41269774) has filed annual accounts for 2025. In 2025, the company reported revenue of DKK 138,591 and a net result of DKK -42 compared with DKK 38,425 the year before. That is a decrease of 43.4% compared with the year before. The profit margin was -0%. Equity in the 2025 report amounted to DKK 49,958. The solvency ratio was 87.7%.
- Revenue
- DKK 138,591
- Gross Profit
- DKK 75,511
- Profit/Loss
- DKK -42
- Equity
- DKK 49,958
- Total Assets
- DKK 56,959
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | 139K | 76K | -42 | 50K | - |
| 2024 | 245K | 236K | 38K | 55K | - |
| 2023 | 250K | 236K | 55K | 16K | - |
| 2022 | 519K | 484K | -56K | -39K | - |
| 2021 | 0 | -14K | -15K | 304K | - |
Official annual report
How creditworthy is MCT Bioseparation Aps?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
MCT Bioseparation Aps has published its annual report for 2024. Revenue came to DKK 244,746, and the net result was DKK 38,425.
About MCT Bioseparation Aps
MCT Bioseparation Aps is a Danish company of the type Anpartsselskab based in Kongens Lyngby, founded in 2020. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Meyer Chroma Technology ApS. The management consists of Jørgen Vonsild Skjøde. The company's owners include John Bagterp Jørgensen, Jørgen Vonsild Skjøde and Jacob Skjøde. The company has 1 employee (2025). In 2025, the company reported revenue of DKK 138,591 and a net result of DKK -42 compared with DKK 38,425 the year before. Equity in the 2025 report amounted to DKK 49,958.